Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
FAQ
- What is Tandem Diabetes Care's D&A?
- Tandem Diabetes Care (TNDM) reported D&A of $4.47M in Q2 2026.
- How has Tandem Diabetes Care's D&A changed year-over-year?
- Tandem Diabetes Care's D&A increased by 2.4% year-over-year, from $4.37M to $4.47M.
- What is the long-term trend for Tandem Diabetes Care's D&A?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's D&A has grown at a 6.3% compound annual growth rate (CAGR), from $13.85M to $17.67M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Tandem Diabetes Care's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude